Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.

Project Information

Tinnitus Platform

Grant agreement ID: 761940

DOI

10.3030/761940

Project closed

EC signature date 29 January 2017

Start date 1 February 2017

End date 31 May 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

KINETIC CENTRUM NOWOCZESNEJ AUDIOLOGII SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Poland

Periodic Reporting for period 1 - Tinnitus Platform (Commercialization of novel Diagnostic Platform with Synaptic adaptation Arc treatment method for tinnitus patients.)

Reporting period: 2017-02-01 to 2017-05-31

Summary of the context and overall objectives of the project

Meeting demand for the first medical device for diagnosis and therapy of tinnitus is set to be a crucial challenge for future audiology and neurology. For that reason Kinetic Center of Advanced Audiology (www.kinetic-cna.pl/) aims to commercialize technologies for the Tinnitus examination and treatment. To do so, co-founders rely on their extensive experience and the interdisciplinary team of: audiologists, laryngologists, medical technicians, neurobiologists, neuroscientists, musical trainers, hearing care professionals, clinicians and nutritionists.
Our main objective today is to bring to the global market a novel “Tinnitus Diagnostic Platform” which is a IT platform of multiple test, that can give more information and indicate with more precision the nature of the tinnitus and “Synaptic adaptation Arc therapy” which is dedicated for tinnitus patients after sudden hearing loss.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

The conducted technology and market analysis demonstrated the viability of the technology to reach the market. We performed analysis of competitive solutions, conducted IPR analysis, identified collaborators and elaborated initial work plan for Phase 2.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The key market application of Tinnitus Diagnostic Platform is to differentiate the pathology of hearing and finally to select appropriate treatment. Synaptic adaptation Arc therapy is based on continuous acoustic stimulation which enforces activity of hear cells and nervous system and gives opportunity to release Arc/Arg 3.1 protein that rebuild synapses. The project addresses the problem of lack of medical device for tinnitus diagnosis and very poor research on the course of the condition.
Finally, to fully exploit and to commercialize this new and EU-based technology, we want to open new Advanced Audiology Clinics around Europe to propose complex methods on hearing pathologies. The Future growth will be driven through sales of Tinnitus Diagnostic Platform to other Audiology Clinics (B2B) and sales of Synaptic adaptation Arc therapy treatment set to patients (B2C).

Tinnitus Platform